Filing Details
- Accession Number:
- 0000950170-24-009429
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-31 16:30:07
- Reporting Period:
- 2024-01-29
- Accepted Time:
- 2024-01-31 16:30:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1991792 | Cg Oncology Inc. | CGON | Biological Products, (No Disgnostic Substances) (2836) | 371611499 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2008157 | Fang Hong Song | C/O Room Nos., 4727-34, Sun Hung Kai Centre, 30 Harbour Road Wanchai K3 0000 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-29 | 350,771 | $0.00 | 350,771 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2024-01-29 | 1,011,192 | $0.00 | 1,011,192 | No | 4 | C | Indirect | By Unique Diamond Investments Limited |
| Common Stock | Acquisiton | 2024-01-29 | 3,930,176 | $0.00 | 3,930,176 | No | 4 | C | Indirect | By Charming Jade Limited |
| Common Stock | Acquisiton | 2024-01-29 | 263,157 | $19.00 | 613,928 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Indirect | By Unique Diamond Investments Limited |
| No | 4 | C | Indirect | By Charming Jade Limited |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Preferred Stock | Disposition | 2024-01-29 | 3,344,608 | $0.00 | 350,771 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2024-01-29 | 6,262,967 | $0.00 | 656,839 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2024-01-29 | 3,378,758 | $0.00 | 354,353 | $0.00 |
| Common Stock | Series E Preferred Stock | Disposition | 2024-01-29 | 37,474,236 | $0.00 | 3,930,176 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferredstock automatically converted into common stock upon the closing of the Issuer's initial public offering.
- Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund,L.P.
- Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare SeedLimited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed toshare beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of theirpecuniary interests therein.
- Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P.
Billionaire Hedge Funds
